Colorectal cancer, endometrial cancer, melanoma, head and neck cancer, lung cancer, MMR-deficient tumors, breast cancer, pancreatic cancer, renal cell carcinoma, solid tumors, urothelial cancer. This evidence concerns the gene MRC1 and hereditary clear cell renal cell carcinoma.